Brandywine Managers’s AbCellera Biologics ABCL Stock Holding History

Brandywine Managers’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.4K	Hold	28,488	–	–	0.06%	40
2025 Q4	$97.4K	Hold	28,488	–	–	0.05%	38
2025 Q3	$143K	Hold	28,488	–	–	0.14%	37
2025 Q2	$97.7K	Hold	28,488	–	–	0.1%	36
2025 Q1	$63.5K	Hold	28,488	–	–	0.08%	35
2024 Q4	$83.5K	Hold	28,488	–	–	0.09%	37
2024 Q3	$74.1K	Hold	28,488	–	–	0.08%	35
2024 Q2	$84.3K	Sell	28,488 -28,488	-50%	-$108K	0.09%	36
2024 Q1	$258K	Hold	56,976	–	–	0.25%	35
2023 Q4	$325K	Hold	56,976	–	–	0.36%	35
2023 Q3	$262K	Hold	56,976	–	–	0.44%	33
2023 Q2	$368K	Hold	56,976	–	–	0.24%	39
2023 Q1	$430K	Hold	56,976	–	–	0.31%	34
2022 Q4	$577K	Hold	56,976	–	–	2.02%	15
2022 Q3	$563K	Hold	56,976	–	–	1.85%	21
2022 Q2	$607K	Buy	56,976 +16,885	+42%	+$143K	1.49%	20
2022 Q1	$391K	Buy	40,091 +2,827	+8%	+$26.8K	0.67%	34
2021 Q4	$533K	Buy	37,264 +6,545	+21%	+$99.3K	0.6%	34
2021 Q3	$616K	Buy	30,719 +5,612	+22%	+$99.2K	0.64%	31
2021 Q2	$552K	Buy	25,107 +5,735	+30%	+$158K	0.63%	33
2021 Q1	$658K	Buy	19,372 +10,436	+117%	+$416K	0.87%	26
2020 Q4	$360K	Buy	+8,936	New	+$409K	0.5%	34

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brandywine Managers's ABCL Position: Q1 2026 in Review

Brandywine Managers held its AbCellera Biologics (ABCL) position steady in Q1 2026 at 28,488 shares worth $99.4K. The position accounts for 0.06% of the portfolio, ranked #40.

Brandywine Managers first reported a position in ABCL in Q4 2020 and has held it in 22 quarters since. The position peaked at $658K in Q1 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

Brandywine Managers held 28,488 shares of AbCellera Biologics worth $99.4K as of Q1 2026.
Brandywine Managers left its AbCellera Biologics share count unchanged in Q1 2026.
AbCellera Biologics made up 0.06% of Brandywine Managers's portfolio in Q1 2026, its #40 holding.
Brandywine Managers first reported a position in AbCellera Biologics in Q4 2020 and has held it in 22 quarters since.
Brandywine Managers's AbCellera Biologics position peaked at $658K in Q1 2021.
138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Brandywine Managers's 13F filing for Q1 2026, filed 14 May 2026.